On February 17, 2009, MTS Medication Technologies, Inc. ("MTS") issued a press release announcing its results of operations for the third quarter and nine months ended December 17, 2009. A copy of the press release is furnished as Exhibit 99.1 to this Report and is incorporated into this Report by reference.

The information in this Form 8-K is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information contained in this Form 8-K and in the accompanying exhibit shall not be incorporated by reference into any registration statement or other document filed with the Securities and Exchange Commission by MTS, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.

The information set forth under Item 2.02 of this Report on Form 8-K is hereby incorporated in this Item 7.01 by reference.

(d) Exhibits.

      Exhibit   Description

       99.1     Press Release of MTS Medication Technologies, Inc., dated
                February 17, 2009 related to the third quarter and nine months
                ended December 31, 2008* (furnished pursuant to Item 2.02).